These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20609915)

  • 1. Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology.
    Yoo MH; Carlson BA; Tsuji P; Irons R; Gladyshev VN; Hatfield DL
    Methods Enzymol; 2010; 474():255-75. PubMed ID: 20609915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells.
    Yoo MH; Xu XM; Carlson BA; Gladyshev VN; Hatfield DL
    J Biol Chem; 2006 May; 281(19):13005-13008. PubMed ID: 16565519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1.
    Su D; Gladyshev VN
    Biochemistry; 2004 Sep; 43(38):12177-88. PubMed ID: 15379556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targets.
    Turanov AA; Kehr S; Marino SM; Yoo MH; Carlson BA; Hatfield DL; Gladyshev VN
    Biochem J; 2010 Sep; 430(2):285-93. PubMed ID: 20536427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication.
    Yoo MH; Xu XM; Carlson BA; Patterson AD; Gladyshev VN; Hatfield DL
    PLoS One; 2007 Oct; 2(10):e1112. PubMed ID: 17971875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings.
    Lechner S; Müller-Ladner U; Neumann E; Spöttl T; Schlottmann K; Rüschoff J; Schölmerich J; Kullmann F
    Lab Invest; 2003 Sep; 83(9):1321-31. PubMed ID: 13679440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of Tetrathionate by Mammalian Thioredoxin Reductase.
    Narayan V; Kudva AK; Prabhu KS
    Biochemistry; 2015 Aug; 54(33):5121-4. PubMed ID: 26252619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thioredoxin reductase--a new target for molecular medical investigations].
    Zagrodzki P
    Postepy Hig Med Dosw; 2002; 56(2):155-67. PubMed ID: 12107960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioredoxin and thioredoxin reductase as redox-sensitive molecular targets for cancer therapy.
    Pennington JD; Jacobs KM; Sun L; Bar-Sela G; Mishra M; Gius D
    Curr Pharm Des; 2007; 13(33):3368-77. PubMed ID: 18045191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin reductase from the malaria mosquito Anopheles gambiae.
    Bauer H; Gromer S; Urbani A; Schnölzer M; Schirmer RH; Müller HM
    Eur J Biochem; 2003 Nov; 270(21):4272-81. PubMed ID: 14622292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase.
    Fujiwara N; Fujii T; Fujii J; Taniguchi N
    J Biochem; 2001 May; 129(5):803-12. PubMed ID: 11328605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
    Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
    Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity assay of mammalian 2-cys peroxiredoxins using yeast thioredoxin reductase system.
    Kim JA; Park S; Kim K; Rhee SG; Kang SW
    Anal Biochem; 2005 Mar; 338(2):216-23. PubMed ID: 15745741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting thioredoxin reductase: anticancer agents and chemopreventive compounds.
    Zeng HH; Wang LH
    Med Chem; 2010 Sep; 6(5):286-97. PubMed ID: 20977412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
    Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
    Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational studies confirm the catalytic triad in the human selenoenzyme thioredoxin reductase predicted by molecular modeling.
    Gromer S; Wessjohann LA; Eubel J; Brandt W
    Chembiochem; 2006 Nov; 7(11):1649-52. PubMed ID: 16977661
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.
    Powis G; Wipf P; Lynch SM; Birmingham A; Kirkpatrick DL
    Mol Cancer Ther; 2006 Mar; 5(3):630-6. PubMed ID: 16546977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells.
    Duan D; Zhang B; Yao J; Liu Y; Fang J
    Free Radic Biol Med; 2014 May; 70():182-93. PubMed ID: 24583460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity.
    Lundström J; Holmgren A
    J Biol Chem; 1990 Jun; 265(16):9114-20. PubMed ID: 2188973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
    Gallegos A; Berggren M; Gasdaska JR; Powis G
    Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.